© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Verici Dx plc (VRCDF) stock remained unchanged at $0.00 a share on OTC. The stock opened at $2.91, fluctuating between $0.00 to $2.91 during the session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Mar 12, 2026 | 2.91 | 2.91 | 2.91 | 2.91 | 200 |
| Sep 18, 2025 | 0.01 | 0.01 | 0.01 | 0.01 | 0 |
| Sep 15, 2025 | 0.01 | 0.01 | 0.01 | 0.01 | 707 |
| Sep 11, 2025 | 0.01 | 0.01 | 0.01 | 0.01 | 0 |
| Sep 08, 2025 | 0.01 | 0.01 | 0.01 | 0.01 | 0 |
| Sep 04, 2025 | 0.01 | 0.01 | 0.01 | 0.01 | 0 |
| Sep 02, 2025 | 0.01 | 0.01 | 0.01 | 0.01 | 707 |
| Aug 26, 2025 | 0.01 | 0.01 | 0.01 | 0.01 | 0 |
| Aug 22, 2025 | 0.01 | 0.01 | 0.01 | 0.01 | 707 |
| Aug 15, 2025 | 0.01 | 0.01 | 0.01 | 0.01 | 0 |
| Aug 12, 2025 | 0.01 | 0.01 | 0.01 | 0.01 | 49K |
| Aug 11, 2025 | 0.01 | 0.01 | 0.01 | 0.01 | 0 |
| Aug 08, 2025 | 0.01 | 0.01 | 0.01 | 0.01 | 0 |
| Aug 06, 2025 | 0.01 | 0.01 | 0.01 | 0.01 | 0 |
| Aug 05, 2025 | 0.01 | 0.01 | 0.01 | 0.01 | 0 |
| Aug 04, 2025 | 0.01 | 0.01 | 0.01 | 0.01 | 0 |
| Jul 31, 2025 | 0.01 | 0.01 | 0.01 | 0.01 | 0 |
| Jul 30, 2025 | 0.01 | 0.01 | 0.01 | 0.01 | 0 |
| Jul 29, 2025 | 0.01 | 0.01 | 0.01 | 0.01 | 0 |
| Jul 28, 2025 | 0.01 | 0.01 | 0.01 | 0.01 | 707 |
Verici Dx plc is an immuno-diagnostics developer primarily dedicated to innovations within the kidney transplantation field. It creates both prognostic (predictive) and diagnostic (identifying current conditions) assays specifically designed for kidney transplant recipients. Its developmental pipeline currently features several key tests: Clarava, a pre-transplant prognostic tool designed to assess the risk of early acute rejection. Tuteva, a post-transplant solution focused on identifying acute cellular rejection. Protega, a novel liquid biopsy that aims to predict the future risk of fibrosis and long-term graft failure. Established in 2020, the company operates from its base in Penarth, United Kingdom.
| Employees | 19 |
| Beta | 1.22 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Diagnostics & Research |